Posted on 2/18/21
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2020
PLANO, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve . . .
Posted on 2/18/21
Safest States During COVID-19 – Updated WalletHub Study
With only 5% of the population fully vaccinated against COVID-19 as of February 17, and vaccination being an essential component for full reopening of the economy, . . .
Posted on 2/18/21
KindHealth Concludes 2020 With $4 Million in Funding
KindHealth, an Austin-based, all-in-one digital health insurance platform, is thrilled to make a capital announcement regarding the company's 2020 performance and future prospects. KindHealth finished 2020 . . .
Posted on 2/18/21
State Launches COVID-19 Vaccine Hotline
Gov. Ralph Northam announced Wednesday that a COVID-19 vaccine hotline, staffed with about 750 customer service employees, has launched. The number is (877) VAX-IN-VA, or (877) . . .
Posted on 2/18/21
Syneos Health Reports Fourth Quarter and Full Year 2020 Results
MORRISVILLE, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today reported financial results for the three and . . .
Posted on 2/18/21
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results
PRINCETON, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December . . .
Posted on 2/18/21
Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
The White House COVID-19 Response Team held a briefing on Wednesday where Joe Biden's recently appointed COVID-19 response coordinator, Jeff Zients, told the public some news . . .
Posted on 2/18/21
NexImmune Closes of Upsized IPO
GAITHERSBURG, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the . . .
Posted on 2/18/21
Veru Announces Prices of Public Offering of Common Stock
MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of . . .
Posted on 2/17/21
Veru Announces Proposed Public Offering of Common Stock
MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of . . .
Posted on 2/17/21
Molecular Templates Announces Proposed Public Offering of Common Stock
AUSTIN, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) , a clinical-stage biopharmaceutical company focused on the discovery and development of the . . .
Posted on 2/17/21
Diffusion Pharmaceuticals Closes $30 Million Bought Deal Offering of Common Stock
CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN), an innovative biopharmaceutical company developing novel therapies to deliver oxygen to areas of . . .
Posted on 2/17/21
Codiak Closes $66.4M Public Offering
CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as . . .
Posted on 2/17/21
Phio Pharmaceuticals Closes $7.7M Registered Direct Offering of Common Stock
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 2/17/21
Overdose-Related Deaths Increase Amid Covid-19 Pandemic
Drug and alcohol-related fatalities in Maryland have increased since the pandemic, and minority communities were hit the hardest, according to a recent report.Between January and September . . .
Posted on 2/17/21
Maryland has Administered More than 900,000 Vaccine Doses
Maryland providers have administered a total of 908,979 coronavirus vaccine doses as of Wednesday morning, representing about 7.5% of the doses needed to fully vaccinate every . . .
Posted on 2/17/21
Citius Pharmaceuticals Prices $76.5 Million Registered Direct Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into definitive . . .
Posted on 2/17/21
Caladrius Biosciences Closes $65 Million Registered Direct Offerings
BASKING RIDGE, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 2/17/21
ICV Partners Majority Investment in Total Access Urgent Care
ICV Partners, LLC, a leading investment firm focused on lower middle market companies in business services, consumer goods & services, food & beverage, and healthcare, announced . . .
Posted on 2/17/21
AIkido Pharma Announces $10 Million Bought Deal Offering Of Common Stock
AIkido Pharma Inc. (Nasdaq: AIKI) today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed . . .
Posted on 2/17/21
Thermo Fisher Scientific Acquires Cell Sorting Technology from Propel Labs
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary . . .
Posted on 2/17/21
Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results
Blueprint Medicines Corporation (NASDAQ:BPMC) today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2020."Last year was . . .
Posted on 2/19/21
Citybiz Interview with Jim Rogers, CEO HealthConnect Networks and Mission Broadband
James E. Rogers, Jr. (Jim) is president of a growing family of telecommunications companies that include HealthConnect Networks
Posted on 2/17/21
Elicio Therapeutics Secures $73 Million in Series B
Elicio Therapeutics, a private biotechnology company developing a pipeline of potent immunotherapies based on its proprietary lymph node targeting technology, announced the successful completion
Posted on 2/17/21
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its fourth quarter and full year 2020 results and recent business . . .
